MX2017002658A - Composiciones sinergicas de virosomas de influenza reconstituidos inmunoestimulantes con inmunopotenciadores y vacunas que los contienen. - Google Patents

Composiciones sinergicas de virosomas de influenza reconstituidos inmunoestimulantes con inmunopotenciadores y vacunas que los contienen.

Info

Publication number
MX2017002658A
MX2017002658A MX2017002658A MX2017002658A MX2017002658A MX 2017002658 A MX2017002658 A MX 2017002658A MX 2017002658 A MX2017002658 A MX 2017002658A MX 2017002658 A MX2017002658 A MX 2017002658A MX 2017002658 A MX2017002658 A MX 2017002658A
Authority
MX
Mexico
Prior art keywords
immunopotentiators
influenza virosomes
adjuvant
reconstituted influenza
vaccines containing
Prior art date
Application number
MX2017002658A
Other languages
English (en)
Inventor
Gupta Gaurav
Fichera Epifanio
Glueck Reinhard
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Publication of MX2017002658A publication Critical patent/MX2017002658A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La presente invención está dirigida a una preparación de un sistema adyuvante destinado a lograr un nivel requerido de respuesta inmunitaria humoral y celular frente al antígeno de interés. La presente invención proporciona un sistema adyuvante que comprende virosomas de infuenza reconstituidos inmunoestimulantes (IRIVs) e inmunopotenciadores. La presente invención ilustra que un antígeno es adsorbido o incorporado en IRIVs y además es formulado con adyuvantes lipofílicos como el MPL o el adyuvante glucopiranosil lípido (análogo sintético del MPL).
MX2017002658A 2014-09-02 2015-09-01 Composiciones sinergicas de virosomas de influenza reconstituidos inmunoestimulantes con inmunopotenciadores y vacunas que los contienen. MX2017002658A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2794MU2014 2014-09-02
PCT/IN2015/000340 WO2016035096A2 (en) 2014-09-02 2015-09-01 Synergistic compositions of immunostimulating reconstituted influenza virosomes with immunopotentiators and vaccines containing them

Publications (1)

Publication Number Publication Date
MX2017002658A true MX2017002658A (es) 2017-09-19

Family

ID=54848870

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017002658A MX2017002658A (es) 2014-09-02 2015-09-01 Composiciones sinergicas de virosomas de influenza reconstituidos inmunoestimulantes con inmunopotenciadores y vacunas que los contienen.

Country Status (10)

Country Link
US (1) US20170296638A1 (es)
EP (1) EP3188756A2 (es)
CN (1) CN109069618A (es)
AR (1) AR101738A1 (es)
AU (1) AU2015310518A1 (es)
BR (1) BR112017003622A2 (es)
CA (1) CA2958219A1 (es)
MX (1) MX2017002658A (es)
TW (1) TW201620926A (es)
WO (1) WO2016035096A2 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2086831C (en) 1991-05-08 1999-03-16 Reinhard Gluck Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
PL2484375T3 (pl) * 2006-09-26 2018-09-28 Infectious Disease Research Institute Kompozycja szczepionki zawierająca syntetyczny adiuwant

Also Published As

Publication number Publication date
AR101738A1 (es) 2017-01-11
AU2015310518A1 (en) 2017-03-09
WO2016035096A2 (en) 2016-03-10
WO2016035096A3 (en) 2016-04-28
CN109069618A (zh) 2018-12-21
EP3188756A2 (en) 2017-07-12
TW201620926A (zh) 2016-06-16
CA2958219A1 (en) 2016-03-10
US20170296638A1 (en) 2017-10-19
BR112017003622A2 (pt) 2017-12-05

Similar Documents

Publication Publication Date Title
PH12016500456A1 (en) Oil-based adjuvant
MX2022002106A (es) Formulaciones de vacuna de vial unico.
WO2019090228A3 (en) Zika vaccines and immunogenic compositions, and methods of using the same
WO2016062020A9 (zh) 茯苓多糖活性组分和成分、其制备方法及用途
MX2018014086A (es) Formulacion que contiene agonista tlr y metodos de uso.
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
IE87439B1 (en) Novel methods for manufacturing an adjuvant
MX2016016746A (es) Composiciones de vacuna con adyuvante dual, preparacion y usos.
PH12015501716A1 (en) Anti-mycoplasma spp. subunit vaccine
WO2016179034A3 (en) Methods and compositions for stimulating immune response using potent immunostimulatory rna motifs
MX2017003794A (es) Formulaciones estables de lipidos y liposomas.
MX2020005584A (es) Vacunacion con particulas de replicon y adyuvante oleoso.
MX2020005554A (es) Vacunas y composiciones inmunogenas para zika y metodos para usarlas.
MX2021007502A (es) Formulaciones y métodos de vacuna de norovirus.
BR112016001686A2 (pt) Vacina, método para a preparação de uma vacina, composição, e, uso de uma composição
BR112018074910A2 (pt) composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito
BR112016021692A2 (pt) Métodos de preparação de uma composição imunogênica e de aperfeiçoamento de potência imunoestimuladora de vacinas adsorvidas em sal de alumínio, composição imunogênica e uso de uma composição de l(mpla)
MX2020002793A (es) Composiciones de microesferas de gas encapsulado en lipidos y metodos relacionados.
MX2018004802A (es) Nuevo adyuvante y composición de vacuna que contiene el mismo.
MX2017002658A (es) Composiciones sinergicas de virosomas de influenza reconstituidos inmunoestimulantes con inmunopotenciadores y vacunas que los contienen.
EA201991319A1 (ru) Вакцины аттенуированного свиного гриппа и способы их изготовления и применения
WO2016039620A3 (en) Respiratory syncytial virus virosomes
LT2014112A (lt) Iš normalių audinių gautos ksenogeninės vakcinos, skirtos pažeisti imuninės sistemos su navikais susijusių antigenų toleravimą
EP2509623A4 (en) METHODS AND COMPOSITIONS USING PEROXIREDOXIN 1 (PRX1) AS ADJUVANT
AR113832A1 (es) Vacunas contra el zika, composiciones inmunogénicas y métodos que las utilizan